Julia P. Dunn

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity

Atul Malhotra, Ronald R. Grunstein, Ingo Fietze et al. · New England Journal of Medicine · 2024 · 511 citations · Full text

The Importance of Caloric Restriction in the Early Improvements in Insulin Sensitivity After Roux-en-Y Gastric Bypass Surgery

James M. Isbell, Robyn A. Tamboli, Erik N. Hansen et al. · Diabetes Care · 2010 · 250 citations · Full text

Tirzepatide as Compared with Semaglutide for the Treatment of Obesity

Louis J. Aronne, Deborah B. Horn, Carel W. le Roux et al. · New England Journal of Medicine · 2025 · 250 citations